GLOBLVIEW
← All stock pages

ABBV

AbbVie Inc // Biotechnology // US
Track ABBV in GLOBLVIEW
Free, no account needed.
Last
$262.51
Day
-0.20%
Open
$261.99
High
$264.00
Low
$260.98
Prev
$263.04
265.97197.38
1 year price history, close only.

How global shocks reach ABBV

Of the 6 shock types GLOBLVIEW tracks, 5 reach this name through its sector (Biotechnology). Stories centred on US also register here as geographic exposure, since that is where it is registered.

ShockChannelTendency for ABBVWhy
OIL SHOCKInput costs tends to be pressuredA jump in oil prices tends to squeeze biotechnology, because fuel and input costs rise faster than prices can be passed on.
CONFLICT RISKRisk appetite tends to be pressuredRising conflict risk tends to weigh on biotechnology, since investors trim exposure to anything read as discretionary or growth-dependent.
CHIP/EXPORTRules and access tends to be pressuredTighter export and chip rules tend to hurt biotechnology, cutting off supply, customers, or both.
TRADE/TARIFFRevenue exposure tends to be pressuredNew tariffs tend to raise costs or shrink markets for biotechnology, since it depends on cross-border supply chains or sales.
RATES/FEDPrice of money tends to be pressuredHigher rates tend to pressure biotechnology, because expected profits sit further out and get discounted harder.

Direction is a tendency across cycles, not a forecast. Sector mapping uses the Finnhub industry classification; geography uses country of registration, not revenue by region.

What is moving it now

Trump says 'hopefully we are towards end' of Iran war - Reuters
CONFLICT RISKRisk appetite tends to pressure biotechnologyReuters · 5h ago
US officials met Iran-backed Houthis in Oman over the weekend, sources say - Reuters
OIL SHOCKInput costs tends to pressure biotechnologyReuters · 5h ago
Fed delivers its first hike in 3 years. Plus, what's moving Starbucks and GE Vernova
RATES/FEDPrice of money tends to pressure biotechnologyCNBC · 10h ago
Yemen offensive elevates enigmatic Houthi commander's standing - Reuters
OIL SHOCKInput costs tends to pressure biotechnologyReuters · 11h ago
Houthi blitz leaves Saudi Arabia exposed, Iran emboldened - Reuters
OIL SHOCKInput costs tends to pressure biotechnologyReuters · 12h ago
Jim Cramer's top 10 things to watch in the stock market Wednesday
RATES/FEDPrice of money tends to pressure biotechnologyCNBC · 15h ago

Key stats

Market cap$463.89B
P/E (TTM)73.67x
EV/EBITDA29.98x
P/S (TTM)7.22x
P/B261.01x
EPS (TTM)$3.56
Div yield2.58%
Beta0.20
52W high$267.47
52W low$190.75
Avg vol (10d)4.35M
Avg vol (3m)6.09M
Gross margin72.79%
Oper margin26.20%
Net margin9.80%
ROE95.59%
Rev growth YoY10.39%
Debt/Equity49.22x

Recent filings

8-KCurrent report2026-08-05
10-QQuarterly report2026-08-03
8-KCurrent report2026-07-31
8-KCurrent report2026-07-06
8-KCurrent report2026-06-22
8-KCurrent report2026-05-12
10-QQuarterly report2026-05-08
8-KCurrent report2026-04-29
8-KCurrent report2026-04-03
8-KCurrent report2026-03-04
8-KCurrent report2026-02-26
10-KAnnual report2026-02-20

Read the reasoning behind these mappings in the Learn section: how world events reach your portfolio and which sectors react to which shocks.

Track ABBV in GLOBLVIEW

Quotes may be delayed. Information only, not investment advice.